IL-1 inhibitor in ascites fluids from ovarian cancer patients.
D000818:Animals; D001202:Ascitic Fluid / Q000378:metabolism*; D002460:Cell Line; D005260:Female; D006801:Humans; D007108:Immune Tolerance; D007111:Immunity, Cellular; D053590:Interleukin 1 Receptor Antagonist Protein; D008213:Lymphocyte Activation; D051379:Mice; D010051:Ovarian Neoplasms / Q000276:immunology*; D011506:Proteins / Q000032:analysis / Q000502:physiology*; D012795:Sialoglycoproteins; D013601:T-Lymphocytes / Q000276:immunology
C507763:IL1RN protein, human; C507764:Il1rn protein, mouse; D053590:Interleukin 1 Receptor Antagonist Protein; D011506:Proteins; D012795:Sialoglycoproteins